Document:

Exhibit 10.18

 

* Confidential Treatment Requested by Celera Corporation*

 

Facility
Participation Agreement

 

This Agreement is entered
into by and between United HealthCare Insurance Company, contracting on behalf
of itself, and the other entities that are United’s Affiliates (collectively
referred to as “United”) and Berkeley Heart Laboratory (“Facility”).

 

This Agreement is effective
on the later of the following dates (the “Effective Date”):

 

i)              December 1,
2007 or

 

ii)             the first day
of the first calendar month that begins at least 30 days after the date when
this Agreement has been executed by all parties.

 

Through contracts with
physicians and other providers of health care services, United maintains one or
more networks of providers that are available to Customers.  Facility is a provider of health care
services.

 

United wishes to arrange to
make Facility’s services available to Customers.  Facility wishes to provide such services,
under the terms and conditions set forth in this Agreement.

 

The parties therefore enter
into this Agreement.

 

Article I.

Definitions

 

The following terms when
used in this Agreement have the meanings set forth below:

 

1.1          “Benefit
Plan” means a certificate of coverage, summary plan description, or
other document or agreement, whether delivered in paper, electronic, or other
format, under which a Payer is obligated to provide coverage of Covered
Services for a Customer.

 

1.2          “Covered
Service” is a health care service or product for which a Customer is
entitled to receive coverage from a Payer, pursuant to the terms of the
Customer’s Benefit Plan with that Payer.

 

1.3          “Customary
Charge” is the fee for health care services charged by Facility that
does not exceed the fee Facility would ordinarily charge another person
regardless of whether the person is a Customer.

 

1.4          “Customer”
is a person eligible and enrolled to receive coverage from a Payer for Covered
Services.

 

1.5          “Payment
Policies” are the guidelines adopted by United outside of this
Agreement for calculating payment of claims to facilities (including claims of
Facility under this Agreement).  The
Payment Policies may change from time to time as discussed in section 5.1 of
this Agreement.

 

	
  UnitedHealthcare
  Facility Agreement

  	
   

  	
  Confidential and
  Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
   

  	
  0507

  

 

1

 

* Confidential Treatment Requested by Celera Corporation*

 

1.6          “Payer”
is an entity obligated to a Customer to provide reimbursement for Covered
Services under the Customer’s Benefit Plan, and authorized by United to access
Facility’s services under this Agreement.

 

1.7          “Protocols”
are the programs, protocols and administrative procedures adopted by United or
a Payer to be followed by Facility in providing services and doing business with
United and Payers under this Agreement. 
These Protocols may include, among other things, credentialing and
recredentialing processes, utilization management and care management
processes, quality improvement, peer review, Customer grievance, concurrent
review, or other similar United or Payer programs.  The Protocols may change from time to time as
discussed in section 4.4 of this Agreement.

 

1.8          “United’s
Affiliates” are those entities controlling, controlled by, or under
common control with, United HealthCare Insurance Company.

 

Article II.

Representations and
Warranties

 

2.1          Representations and Warranties of Facility.  Facility, by virtue
of its execution and delivery of this Agreement, represents and warrants as
follows:

 

a)             Facility
is a duly organized and validly existing legal entity in good standing under
the laws of its jurisdiction of organization.

 

b)            Facility
has all requisite corporate power and authority to conduct its business as
presently conducted, and to execute, deliver and perform its obligations under
this Agreement.  The execution, delivery
and performance of this Agreement by Facility have been duly and validly
authorized by all action necessary under its organizational documents and
applicable corporate law.  This Agreement
has been duly and validly executed and delivered by Facility and (assuming the
due authorization, execution and delivery of this Agreement by United)
constitutes a valid and binding obligation of Facility, enforceable against
Facility in accordance with its terms, except as such enforceability may be
limited by the availability of equitable remedies or defenses and by applicable
bankruptcy, insolvency, reorganization, moratorium or similar laws affecting
the enforcement of creditors’ rights generally.

 

c)             The
execution, delivery and performance of this Agreement by Facility do not and
will not violate or conflict with (i) the organizational documents of
Facility, (ii) any material agreement or instrument to which Facility is a
party or by which Facility or any material part of its property is bound, or (iii) applicable
law.

 

d)            Facility
has obtained and holds all registrations, permits, licenses, and other
approvals and consents, and has made all filings, that it is required to obtain
from or make with all governmental entities under applicable law in order to
conduct its business as presently conducted and to enter into and perform its
obligations under this Agreement.

 

e)             Facility
has been given an opportunity to review the Protocols and Payment Policies and
acknowledges that it is bound by the Protocols and that claims under this
Agreement will be paid in accordance with the Payment Policies.

 

f)             Each
submission of a claim by Facility pursuant to this Agreement shall be deemed to
constitute the representation and warranty by it to United that (i) the
representations and

 

	
  UnitedHealthcare
  Facility Agreement

  	
   

  	
  Confidential and
  Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
   

  	
  0507

  

 

2

 

* Confidential Treatment Requested by Celera Corporation*

 

warranties of it set forth in this section 2.1 and elsewhere
in this Agreement are true and correct as of the date the claim is submitted, (ii) it
has complied with the requirements of this Agreement with respect to the
Covered Services involved and the submission of such claim, (iii) the
charge amount set forth on the claim is the Customary Charge and (iv) the
claim is a valid claim.

 

2.2          Representations and Warranties of United.  United, by virtue of
its execution and delivery of this Agreement, represents and warrants as
follows:

 

a)             United
is a duly organized and validly existing legal entity in good standing under
the laws of its jurisdiction of organization.

 

b)            United
has all requisite corporate power and authority to conduct its business as
presently conducted, and to execute, deliver and perform its obligations under
this Agreement.  The execution, delivery
and performance of this Agreement by United have been duly and validly
authorized by all action necessary under its organizational documents and
applicable corporate law.  This Agreement
has been duly and validly executed and delivered by United and (assuming the
due authorization, execution and delivery of this Agreement by Facility) constitutes
a valid and binding obligation of United, enforceable against United in
accordance with its terms, except as such enforceability may be limited by the
availability of equitable remedies or defenses and by applicable bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting the
enforcement of creditors’ rights generally.

 

c)             The
execution, delivery and performance of this Agreement by United do not and will
not violate or conflict with (i) the organizational documents of United, (ii) any
material agreement or instrument to which United is a party or by which United
or any material part of its property is bound, or (iii) applicable law.

 

d)            United
has obtained and holds all registrations, permits, licenses, and other
approvals and consents, and has made all filings, that it is required to obtain
from or make with all governmental entities under applicable law in order to
conduct its business as presently conducted and to enter into and perform its
obligations under this Agreement.

 

Article III.

Applicability of this
Agreement

 

3.1          Facility’s Services.  This Agreement
applies to Covered Services provided at Facility’s service locations set forth
in Appendix 1.  In the event Facility
begins providing new service types, or services at other locations or under
other tax identification number(s), (either by operating such locations itself,
or by acquiring, merging or affiliating with an existing provider that was not
already under contract with United or one of United’s Affiliates to participate
in a network of health care providers), such additional tax identification
numbers, service types, or locations will become subject to this Agreement only
upon the written agreement of the parties.

 

In
the event Facility acquires or is acquired by, merges with, or otherwise
becomes affiliated with another provider of health care services that is
already under contract with United or one of United’s Affiliates to participate
in a network of health care providers, the non-payment terms of this Agreement
will remain in effect and supersede the terms and conditions of the other
agreement.  In the case of such
affiliation, the payment rates for Covered Services set forth in the continuing
Agreement will be the lesser of (1) the rates set forth in the other

 

	
  UnitedHealthcare
  Facility Agreement

  	
   

  	
  Confidential and
  Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
   

  	
  0507

  

 

3

 

* Confidential Treatment Requested by Celera Corporation*

 

agreement between another
provider of health care services and United, or (2) the rates set forth in
the applicable Payment Appendix to this Agreement.

 

Facility will not transfer
all or some of its assets to any other entity during the term of this
Agreement, with the result that all or some of the Covered Services subject to
this Agreement will be rendered by the other entity rather than by Facility,
without the express written agreement of United.

 

3.2          Payers and Benefit
Plan types.  United may allow Payers to access Facility’s
services under this Agreement for the Benefit Plan types described in Appendix
2.  Appendix 2 may be modified by United
upon 30 days written or electronic notice.

 

3.3          Services not covered
under a Benefit Plan.  This Agreement does not apply to services not
covered under the applicable Benefit Plan. 
Facility may seek and collect payment from a Customer for such services,
provided that the Facility first obtain the Customer’s written consent.

 

This section does not
authorize Facility to bill or collect from Customers for Covered Services for
which claims are denied or otherwise not paid. 
That issue is addressed in sections 6.5 and 6.8 of this Agreement.

 

3.4          Patients who are not
Customers.  This Agreement does not apply to services
rendered to patients who are not Customers at the time the services were rendered.  Section 6.6 of this Agreement addresses
circumstances in which claims for services rendered to such persons are
inadvertently paid.

 

3.5          Health Care.  Facility acknowledges
that this Agreement and Customer Benefit Plans do not dictate the health care
provided by Facility, or govern a physician’s or hospital’s determination of
what care to provide its patients, even if those patients are Customers.  The decision regarding what care is to be
provided remains with Customers and their physicians, and not with United or
any Payer.

 

3.6          Communication with
Customers.  Nothing in this Agreement is intended to
limit Facility’s right or ability to communicate fully with a Customer and the
Customer’s physician regarding the Customer’s health condition and treatment
options.  Facility is free to discuss all
treatment options without regard to whether or not a given option is a Covered
Service.  Facility is free to discuss
with a Customer any financial incentives Facility may have under this Agreement,
including describing at a general level the payment methodologies contained in
this Agreement.

 

Article IV.

Duties of Facility

 

4.1          Provide Covered Services.  Facility will provide
Covered Services to Customers.  Facility
must be in compliance with section 2.1(d) of this Agreement and
credentialed by United or its delegate prior to furnishing any Covered Services
to Customers under this Agreement.

 

4.2          Nondiscrimination.  Facility will not
discriminate against any patient, with regard to quality of service or
accessibility of services, on the basis that the patient is a Customer.

 

4.3          Accessibility.  Facility will be open 24 hours a day, seven
days a week.

 

	
  UnitedHealthcare
  Facility Agreement

  	
   

  	
  Confidential and
  Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
   

  	
  0507

  

 

4

 

* Confidential Treatment Requested by Celera Corporation*

 

4.4          Cooperation with Protocols.  Facility will
cooperate with and be bound by United’s and Payers’ Protocols.  The Protocols include but are not limited to
all of the following:

 

1)             Facility will use reasonable commercial efforts to direct
Customers only to other providers that participate in United’s network, except
as permitted under the Customer’s Benefit Plan or otherwise authorized by
United or Payer.

 

2)             Facility will make its best efforts to assure that all
Facility-based physician groups participate in United’s network as long as this
Agreement is in effect.

 

In the event that a
Facility-based physician group is not a participating provider with United,
Facility’s Chief Financial Officer or equivalent senior level officer (“Facility
Representative”) will assist United in its efforts to negotiate an agreement
with such group.  Upon request by United,
Facility Representative will:

 

a)             meet with
Facility-based physician group to encourage participation.  Facility Representative shall provide United
with meeting minutes of any such meeting within 15 days.  Meeting minutes will include a summary of the
key discussion points and an outline of any actionable resolution options
deemed by Facility Representative.

 

b)            write
letter(s) to Facility-based physician group encouraging the group to
negotiate in good faith with United.  The
letter will also outline any contractual requirements in the agreement between Facility
and Facility-based physician group that requires Facility-based physician group
to (1) negotiate in good faith with third party payers, (2) participate
in third party payer networks, and (3) other provisions related to
Facility-based physician group’s participation with third party payers.

 

c)             invoke
any applicable penalties or other contractual terms in its agreement with
Facility-based physician group related to its non-participating status with a
third party payer.

 

d)            allow
independent legal counsel (mutually agreeable to all relevant parties) to
review Facility/Facility-based physician agreement to ensure Facility is fully
invoking all the relevant terms and conditions of such agreement to require or
promote Facility-based physician group’s participation status with United.

 

United warrants that it will
negotiate with Facility-based physician groups in good faith.  Facility acknowledges that United will have
no responsibility for the credentialing of any employed or sub-contracted
Facility-based provider.

 

3)             Facility will provide notification for certain Covered
Services, accept and return telephone calls from United staff, and respond to
United requests for clinical information, as required by United or Payer as
described in the Protocols.

 

The Protocols will be made
available to Facility online or upon request. 
Some or all Protocols also may be disseminated in the form of an
administrative manual or guide or in other communications.

 

United
may change the Protocols from time to time. 
United will use reasonable commercial efforts to inform Facility at
least 30 days in advance of any material changes to the Protocols.  United may implement changes in the Protocols
without Facility’s consent if such change is applicable to all or substantially
all of the facilities in United’s network located in the same state

 

	
  UnitedHealthcare
  Facility Agreement

  	
   

  	
  Confidential and
  Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
   

  	
  0507

  

 

5

 

* Confidential Treatment Requested by Celera Corporation*

 

as Facility.  Otherwise, changes to the Protocols proposed
by United to be applicable to Facility are subject to the terms of section 9.2
of this Agreement applicable to amendments.

 

4.5          Employees and subcontractors.  Facility will assure
that its employees, affiliates and any individuals or entities subcontracted by
Facility to render services in connection with this Agreement adhere to the
requirements of this Agreement.  The use
of employees, affiliates or subcontractors to render services in connection
with this Agreement will not limit Facility’s obligations and accountability
under this Agreement with regard to such services.  Facility affiliates are those entities that
control, are controlled by or are under common control with Facility.

 

4.6          Licensure.  Facility will maintain, without material
restriction, such licensure, registration, and permits as are necessary to
enable Facility to lawfully perform this Agreement.

 

4.7          Liability Insurance.  Facility shall
procure and maintain liability insurance. 
Except to the extent coverage is a state mandated placement, Facility’s
coverage must be placed with responsible, financially sound insurance carriers
authorized or approved to write coverage in the state in which the Covered Services
are provided.  Facility’s liability
insurance shall be, at a minimum, of the types and in the amounts set forth
below.  Facility’s medical malpractice
insurance shall be either occurrence or claims made with an extended period
reporting option.  Prior to the Effective
Date of this Agreement and within 10 days of each policy renewal thereafter,
Facility shall submit to United in writing evidence of insurance coverage.

 

	
  TYPE OF INSURANCE

  	
   

  	
  MINIMUM LIMITS

  
	
   

  	
   

  	
   

  
	
  Medical malpractice and/or professional liability insurance

  	
   

  	
  Five Million Dollars ($5,000,000.00) per occurrence and aggregate

  
	
   

  	
   

  	
   

  
	
  Commercial general and/or umbrella liability insurance

  	
   

  	
  Five Million Dollars ($5,000,000.00) per occurrence and aggregate

  

 

In lieu of purchasing the
insurance coverage required in this section, Facility may, with the prior
written approval of United, self-insure its medical malpractice and/or
professional liability, as well as its commercial general liability.  Facility shall maintain a separate reserve
for its self-insurance.  Prior to the
Effective Date, Facility shall provide a statement, verified by an independent
auditor or actuary, that its reserve funding levels and process of funding
appears adequate to meet the requirements of this section and fairly represents
the financial condition of the fund. 
Facility will provide a similar statement during the term of this
Agreement upon United’s request, which will be made no more frequently than
annually.  Facility will assure that its
self-insurance fund will comply with applicable laws and regulations.

 

4.8          Notice.  Facility will give
notice to United within 10 days after any event that causes Facility to be out
of compliance with section 4.6 or 4.7 of this Agreement, or of any change in
Facility’s name, ownership, control, or Taxpayer Identification Number.  In addition, Facility will give written
notice to United 45 days prior to the effective date of changes in existing
remit address(es) and other demographic information.

 

	
  UnitedHealthcare
  Facility Agreement

  	
   

  	
  Confidential and
  Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
   

  	
  0507

  

 

6

 

* Confidential Treatment Requested by Celera Corporation*

 

4.9          This section intentionally left blank.

 

4.10        Maintenance of and
Access to Records.  Facility will maintain adequate medical,
financial and administrative records related to Covered Services rendered by
Facility under this Agreement, including claims records, for at least 6 years
following the end of the calendar year during which the Covered Services are
provided, unless a longer retention period is required by applicable law.

 

Facility will provide access
to these records as follows:

 

i) to United or its
designees, in connection with United’s utilization management/Care CoordinationsSM, quality assurance and
improvement and for claims payment and other administrative obligations,
including reviewing Facility’s compliance with the terms and provisions of this
Agreement and appropriate billing practice. 
Facility will provide access during ordinary business hours within
fourteen days after a request is made, except in cases of a United audit
involving a fraud investigation or the health and safety of a Customer (in
which case, access shall be given within 48 hours after the request) or of an
expedited Customer appeal or grievance (in which case, access will be given so
as to enable United to reasonably meet the timelines for determining the appeal
or grievance); and

 

ii) to agencies of the
government, in accordance with applicable law, to the extent such access is
necessary to comply with regulatory requirements applicable to Facility,
United, or Payers.

 

Facility will cooperate with
United on a timely basis in connection with any such audit including, among
other things, in the scheduling of and participation in an audit exit interview
within 30 days of United’s request.

 

If such information and
records are requested by United, Facility shall provide copies of such records
free of charge.

 

4.11        Access to Data.  Facility represents
that in conducting its operations, it collects and reviews certain quality data
relating to care rendered by Facility that is reported in a manner which has
been validated by a third party as having a clear, evidence-based link to
quality or safety (e.g., AHRQ standards) or which has been created by employer
coalitions as proxies for quality (e.g., Leapfrog standards).

 

United recognizes that
Facility has the sole discretion to select the metrics which it will track from
time to time and that Facility’s primary goal in so tracking is to advance the
quality of patient care.  If the
information that a facility chooses to report on is available in the public
domain in a format that includes all data elements required by UnitedHealthcare,
UnitedHealthcare will obtain quality information directly from the source to
whom the facility reported.  If the
facility does not report metrics in the public domain, on a quarterly basis,
Facility will share these metrics with United as tracked against a database of
all discharged, commercial patients (including patients who are not United
customers).  United may publish this data
to entities to which United renders services or seeks to render services, and
to Customers.

 

4.12        Compliance with law.  Facility will comply
with applicable regulatory requirements, including but not limited to those
relating to confidentiality of Customer medical information.

 

4.13        Electronic connectivity.  When made available by United, Facility will
communicate with United electronically. 
Facility will use www.unitedhealthcareonline.com to check eligibility

 

	
  UnitedHealthcare
  Facility Agreement

  	
   

  	
  Confidential and
  Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
   

  	
  0507

  

 

7

 

* Confidential Treatment Requested by Celera Corporation*

 

status, claims status, and submit requests for claims
adjustment for products supported by UnitedHealthcare Online® or other online
resources as supported for additional products. 
Facility agrees to use www.unitedhealthcareonline.com for additional
functionalities (for instance, notification of admission) after United informs
Facility that such functionalities have become available for the applicable
Customer.

 

4.14        Implementation of
Patient Safety Programs.  Facility will implement quality programs
rcconunended by nationally recognized independent third parties on a reasonably
prompt basis.

 

4.15        Performance Standards
and Guarantees.  Facility hereby accepts and agrees to the
performance standards and guarantees set forth in the Performance Standards and
Guarantees Appendix attached to this Agreement, including the payment which
shall be at risk should Facility’s performance fall below the indicated
targets.

 

Article V.

Duties of United and
Pavers

 

5.1          Payment of Claims.  As described in further
detail in Article VI of this Agreement, Payers will pay Facility for
rendering Covered Services to Customers. 
United will make its Payment Policies available to Facility online or
upon request.  United may change its
Payment Policies from time to time.

 

5.2          Liability Insurance.  United will procure
and maintain professional and general liability insurance and other insurance,
as United reasonably determines may be necessary, to protect United and
United’s employees against claims, liabilities, damages or judgments that arise
out of services provided by United or United’s employees under this Agreement.

 

5.3          Licensure.  United will maintain,
without material restriction, such licensure, registration, and permits as are
necessary to enable United to lawfully perform this Agreement.

 

5.4          Notice.  United will give
written notice to Facility within 10 days after any event that causes United to
be out of compliance with section 5.2 or 5.3 of this Agreement, or of any
change in United’s name, ownership, control, or Taxpayer Identification
Number.  This section does not apply to
changes of ownership or control that result in United being owned or controlled
by an entity with which it was already affiliated prior to the change.

 

5.5          Compliance with law.  United will comply
with applicable regulatory requirements, including but not limited to those
relating to confidentiality of Cu9stomer medical information and those relating
to prompt payment of claims, to the extent those requirements are applicable.

 

5.6          Electronic
connectivity.  United will communicate with Facility
electronically by providing eligibility status, claims status, and accepting
requests for claim adjustments, for those products supported by
www.unitedhealthcareonline.com. United will communicate enhancements in
www.unitedhealthcareonline.com functionality as they become available, as
described in Section 4.13, and will make information available as to which
products are supported by www.unitedhealthcareonline.com.

 

5.7          Employees and
subcontractors.  United will assure that its employees,
affiliates and any individuals or entities subcontracted by United to render
services in connection with this Agreement adhere to the requirements of this
Agreement.  The use of employees,
affiliates or

 

	
  UnitedHealthcare
  Facility Agreement

  	
   

  	
  Confidential and
  Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
   

  	
  0507

  

 

8

 

* Confidential Treatment Requested by Celera Corporation*

 

subcontractors to render services in connection with this
Agreement will not limit United’s obligations and accountability under this
Agreement with regard to such services.

 

Article VI.

Submission,
Processing. and Payment of Claims

 

6.1          Form and content
of claims.  Facility must submit claims for Covered
Services in a manner and format prescribed by United, as further described in
the Protocols.  Unless otherwise directed
by United, Facility shall submit claims using current CMS 1500 or UB92 forms
for paper claims and HIPAA standard professional or institutional claim formats
for electronic claims, as applicable, with applicable coding including, but not
limited to, ICD-9-CM, CPT, Revenue and HCPCS coding.

 

6.2          Electronic filing of claims.  Within six months
after the Effective Date of this Agreement, Facility will use electronic
submission for all of its claims under this Agreement that United is able to
accept electronically.

 

6.3          Time to file claims.  All information
necessary to process a claim must be received by United no more than 90 days
from the date Covered Services are rendered. 
In the event United requests additional information in order to process
the claim, Facility will provide such additional information within 90 days of
United’s request.  If Payer is not the
primary payer, and Facility is pursuing payment from the primary payer, the 90
day filing limit will begin on the date Facility receives the claim response
from the primary payer.

 

6.4          Payment of claims.  Payer will pay claims
for Covered Services as further described in the applicable Payment Appendix to
this Agreement and in accordance with Payment Policies.

 

Claims for Covered Services
subject to coordination of benefits will be paid in accordance with the
Customer’s Benefit Plan and applicable state and federal law.

 

The obligation for payment
under this Agreement is solely that of Payer, and not that of United unless
United is the Payer.

 

6.5          Denial of Claims for Not Following Protocols
or Not Filing Timely.  Payment may be denied in whole or in part if
Facility does not comply with a Protocol or does not file a timely claim under
section 6.3 of this Agreement.

 

In the event that payment of
a claim is denied for lack of notification or for untimely filing, the denial
will be reversed if Facility appeals within 12 months after the date of denial
and can show all of the following:

 

	
  i)

  	
   

  	
  that, at the time the Protocols
  required notification or at the time the claim was due, Facility did not know
  and was unable to reasonably determine that the patient was a Customer,

  
	
  ii)

  	
   

  	
  that Facility took reasonable
  steps to learn that the patient was a Customer, and

  
	
  iii)

  	
   

  	
  that Facility promptly provided
  notification, or filed the claim, after learning that the patient was a
  Customer.

  

 

6.6          Retroactive correction of information
regarding whether patient is a Customer.  Prior to rendering services, Facility shall
ask the patient to present his or her Customer identification card.

 

	
  UnitedHealthcare
  Facility Agreement

  	
   

  	
  Confidential and
  Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
   

  	
  0507

  

 

9

 

* Confidential Treatment Requested by Celera Corporation*

 

In addition, Facility may contact United to obtain the most
current information on the patient as a Customer.

 

However, Facility
acknowledges that such information provided by United is subject to change
retroactively, under the following circumstances, (1) if United has not
yet received information that an individual is no longer a Customer; (2) if
the individual’s Benefit Plan is terminated retroactively for any reason
including, but not limited to, non-payment of premium; (3) as a result of
the Customer’s final decision regarding continuation of coverage pursuant to
state and federal laws; or (4) if eligibility information United receives
is later proven to be false.

 

If Facility provides health
care services to an individual, and it is determined that the individual was
not a Customer at the time the health care services were provided, those
services shall not be eligible for payment under this Agreement and any claims
payments made with regard to such services may be recovered as overpayments
under the process described in section 6.10 of this Agreement.  Facility may then directly bill the
individual, or other responsible party, for such services.

 

6.7          Payment under this Agreement is payment in
full. 
Payment as provided under section 6.4, together with any co-payment,
deductible or coinsurance for which the Customer is responsible under the
Benefit Plan, is payment in full for a Covered Service.  Facility will not seek to recover, and will
not accept, any payment from Customer, United, Payer or anyone acting in their
behalf, in excess of payment in full as provided in this section 6.7,
regardless of whether such amount is less than Facility’s billed charge or Customary
Charge.

 

6.8          Customer “Hold Harmless.”  Facility will not
bill or collect payment from the Customer, or seek to impose a lien, for the
difference between the amount paid under this Agreement and Facility’s billed
charge or Customary Charge, or for any amounts denied or not paid under this
Agreement due to:

 

	
  i)

  	
   

  	
  Facility’s failure to comply with
  the Protocols,

  
	
  ii)

  	
   

  	
  Facility’s failure to file a
  timely claim,

  
	
  iii)

  	
   

  	
  Payer’s Payment Policies,

  
	
  iv)

  	
   

  	
  inaccurate or incorrect claim
  processing,

  
	
  v)

  	
   

  	
  insolvency or other failure by
  Payer to maintain its obligation to fund claims payments, if Payer is United,
  or is an entity required by applicable law to assure that its Customers not
  be billed in such circumstances.

  

 

This obligation to refrain
from billing Customers applies even in those cases in which Facility believes
that United or Payer has made an incorrect determination.  In such cases, Facility may pursue remedies
under this Agreement against United or Payer, as applicable, but must still
hold the Customer harmless.

 

In the event of a default by
a Payer other than those Payers covered by subsection v) of this Section 6.8,
Facility may seek payment directly from the Payer or from Customers covered by
that Payer.  However, Facility may do so
only if it first inquires in writing to United as to whether the Payer has
defaulted and, in the event that United confirms that Payer has defaulted
(which confirmation will not be unreasonably withheld), Facility then gives
United 15 days prior written notice of Facility’s intent to seek payment from
Payer or Customers.  For purposes of this
paragraph, a default is a systematic failure by a Payer to fund claims payments
related to Customers covered through that Payer; a default does not occur in
the case of a dispute as to whether certain claims should be paid or the
amounts that should be paid for certain claims.

 

	
  UnitedHealthcare
  Facility Agreement

  	
   

  	
  Confidential and
  Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
   

  	
  0507

  

 

10

 

* Confidential
Treatment Requested by Celera Corporation*

 

This section
6.8 and section 6.7 will survive the termination of this Agreement, with regard
to Covered Services rendered prior to when the termination takes effect.

 

6.9          Consequences
for failure to adhere to Customer protection requirements. 
If Facility collects payment from, brings a collection action against,
or asserts a lien against a Customer for Covered Services rendered (other than
for the applicable co-payment, deductible or coinsurance), contrary to section
6.7 or 6.8 of this Agreement, Facility shall be in breach of this
Agreement.  This section 6.9 will apply
regardless of whether Customer or anyone purporting to act on Customer’s behalf
has executed a waiver or other document of any kind purporting to allow
Facility to collect such payment from Customer.

 

In the event
of such a breach, Payer may deduct, from any amounts otherwise due Facility,
the amount wrongfully collected from Customers, and may also deduct an amount
equal to any costs or expenses incurred by the Customer, United or Payer in
defending the Customer from such action and otherwise enforcing sections 6.7
through 6.9 of this Agreement.  Any
amounts deducted by Payer in accordance with this provision shall be used to
reimburse the Customer and to satisfy any costs incurred.  The remedy contained in this paragraph does
not preclude United from invoking any other remedy for breach that may be
available under this Agreement.

 

6.10        Correction
of overpayments or underpayments of claims. 
In the event that either Party believes that a claim has not been paid
correctly, or that funds were paid beyond or outside of what is provided for
under this Agreement, either party may seek correction of the payment, except
that Facility may not seek correction of a payment more than 12 months after it
was made.

 

Facility will
repay overpayments within 30 days of notice of the overpayment.  Facility will promptly report any credit
balance that it maintains with regard to any claim overpayment under this
Agreement, and will return such overpayment to United within 30 days after
posting it as a credit balance.

 

Facility
agrees that recovery of overpayments may be accomplished by offsets against
future payments.

 

Article VII.

Dispute
Resolution

 

The parties
will work together in good faith to resolve any and all disputes between them
(hereinafter referred to as “Disputes”) including but not limited to all
questions of arbitrability, the existence, validity, scope or termination of
the Agreement or any term thereof.

 

If the parties
are unable to resolve any such Dispute within 60 days following the date one
party sent written notice of the Dispute to the other party, and if either
party wishes to pursue the Dispute, it shall thereafter be submitted to binding
arbitration before a panel of three arbitrators in accordance with the
Commercial Dispute Procedures of the American Arbitration Association, as they
may be amended from time to time (see http://www.adr.org).  Unless otherwise agreed to in writing by the
parties, the party wishing to pursue the Dispute must initiate the arbitration within
one year after the date on which notice of the Dispute was given or shall be
deemed to have waived its right to pursue the dispute in any forum.

 

	
  UnitedHealthcare
  Facility Agreement

  	
  Confidential
  and Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
  0507

  

 

11

 

* Confidential
Treatment Requested by Celera Corporation*

 

Any
arbitration proceeding under this Agreement shall be conducted in San Francisco
County, CA.  The arbitrator(s) may
construe or interpret but shall not vary or ignore the terms of this Agreement
and shall be bound by controlling law. 
The arbitrator(s) shall have no authority to award punitive,
exemplary, indirect or special damages, except in connection with a statutory
claim that explicitly provides for such relief.

 

The parties
expressly intend that any dispute relating to the business relationship between
them be resolved on an individual basis so that no other dispute with any third
party(ies) may be consolidated or joined with the dispute.  The parties agree that any arbitration ruling
by an arbitrator allowing class action arbitration or requiring consolidated arbitration
involving any third party(ies) would be contrary to their intent and would
require immediate judicial review of such ruling.

 

If the Dispute
pertains to a matter which is generally administered by certain United
procedures, such as a credentialing or quality improvement plan, the policies
and procedures set forth in that plan must be fully exhausted by Facility
before Facility may invoke any right to arbitration under this Article VII.

 

The decision
of the arbitrator(s) on the points in dispute will be binding, and
judgment on the award may be entered in any court having jurisdiction
thereof.  The parties acknowledge that
because this Agreement affects interstate commerce the Federal Arbitration Act
applies.

 

In the event
that any portion of this Article or any part of this Agreement is deemed
to be unlawful, invalid or unenforceable, such unlawfulness, invalidity or
unenforceability shall not serve to invalidate any other part of this Article or
Agreement.  In the event any court
determines that this arbitration procedure is not binding or otherwise allows
litigation involving a Dispute to proceed, the parties hereby waive any and all
right to trial by jury in, or with respect to, such litigation.  Such litigation would instead proceed with
the judge as the finder of fact.

 

In the event a
party wishes to terminate this Agreement based on an assertion of uncured
material breach, and the other party disputes whether grounds for such a
termination exist, the matter will be resolved through arbitration under this Article VII.  While such arbitration remains pending, the
termination for breach will not take effect.

 

This Article VII
governs any dispute between the parties arising before or after execution of
this Agreement, and shall survive any termination of this Agreement.

 

Article VIII.

Term and
Termination

 

8.1          Term. 
This Agreement shall take effect on the Effective Date.  This Agreement shall have an initial term of
[* * *], until terminated pursuant to Section 8.2.

 

8.2          Termination. 
This Agreement may be terminated under any of the following
circumstances:

 

	
  i)

  	
   

  	
  by mutual written
  agreement of the parties;

  
	
  ii)

  	
   

  	
  by either party,
  upon at least 180 days prior written notice, effective at the end of year
  three, the end of year four, the end of the initial term, or effective at the
  end of any renewal term;

  

 

	
  UnitedHealthcare
  Facility Agreement

  	
  Confidential
  and Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
  0507

  

 

12

 

* Confidential
Treatment Requested by Celera Corporation*

 

	
  iii)

  	
   

  	
  by either party upon
  60 days written notice in the event of a material breach of this Agreement by
  the other party, except that such a termination will not take effect if the
  breach is cured within 60 days after notice of the termination; moreover,
  such termination may be deferred as further described in Article VII of
  this Agreement;

  
	
  iv)

  	
   

  	
  by either party
  upon 10 days written notice in the event the other party loses licensure or
  other governmental authorization necessary to perform this Agreement, or
  fails to have insurance as required under section 4.7 or section 5.2 of this
  Agreement;

  
	
  v)

  	
   

  	
  by United upon 10
  days written notice in the event Facility loses accreditation;

  
	
  vi)

  	
   

  	
  by United, upon 90
  days notice, in the event:

  
	
   

  	
   

  	
  a)

  	
  Facility loses approval for participation
  under United’s credentialing plan, or

  
	
   

  	
   

  	
  b)

  	
  Facility does not successfully complete the
  United’s re-credentialing process as required by the credentialing plan;

  
	
  vii)

  	
   

  	
  by United upon 10
  days written notice in the event there is any change in the controlling interest
  of Facility modifying the percentage ownership interest outlined in exhibit 2
  to this Agreement.

  

 

8.3          Ongoing
Services to Certain Customers After Termination Takes Effect. 
In the event a Customer is receiving any of the Covered Services, as of
the date the termination takes effect, Facility will continue to render those
Covered Services to that Customer, and this Agreement will continue to apply to
those Covered Services, after the termination takes effect, until the earlier
of: the Covered Services are complete or 30 days after termination.

 

Article IX.

Miscellaneous
Provisions

 

9.1          Entire
Agreement.  This Agreement is the entire agreement
between the parties with regard to the subject matter herein, and supersedes
any prior written or unwritten agreements between the parties or their
affiliates with regard to the same subject matter.

 

9.2          Amendment. 
This Agreement may only be amended in a writing signed by both parties,
except that this Agreement may be unilaterally amended by United upon written
notice to Facility in order to comply with applicable regulatory
requirements.  United will provide at
least 30 days notice of any such regulatory amendment, unless a shorter notice
is necessary in order to accomplish regulatory compliance.

 

9.3          Nonwaiver. 
The waiver by either party of any breach of any provision of this
Agreement shall not operate as a waiver of any subsequent breach of the same or
any other provision.

 

9.4          Assignment. 
This Agreement may not be assigned by either party without the written
consent of the other party, except that this Agreement may be assigned by
United to any of United’s Affiliates.

 

9.5          Relationship
of the Parties.  The sole
relationship between the parties to this Agreement is that of independent
contractors.  This Agreement does not
create a joint venture, partnership, agency, employment or other relationship
between the parties.

 

9.6          No
Third-Party Beneficiaries.  United and
Facility are the only entities with rights and remedies under the Agreement.

 

	
  UnitedHealthcare
  Facility Agreement

  	
  Confidential
  and Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
  0507

  

 

13

 

* Confidential
Treatment Requested by Celera Corporation*

 

9.7          Delegation. 
United may delegate (but not assign) certain of its administrative
duties under this Agreement to one or more other entities.  No such delegation will relieve United of its
obligations under this Agreement.

 

9.8          Notice. 
Any notice required to be given under this Agreement shall be in
writing, except in cases in which this Agreement specifically permits
electronic notice, or as otherwise permitted or required in the Protocols.  All written or electronic notices shall be
deemed to have been given when delivered in person, by electronic communication,
by facsimile or, if delivered by first-class United States mail, on the date
mailed, proper postage prepaid and properly addressed to the appropriate party
at the address set forth on the signature portion of this Agreement or to
another more recent address of which the sending party has received written
notice.  Notwithstanding the previous
sentence, all notices of termination of this Agreement by either party must be
sent by certified mail, return receipt requested.  Each party shall provide the other with
proper addresses, facsimile numbers and electronic mail addresses of all
designees that should receive certain notices or communication instead of that
party.

 

9.9          Confidentiality. 
Neither party will disclose to a Customer, other health care providers,
or other third parties any of the following information (except as required by
an agency of the government):

 

a) any
proprietary business information, not available to the general public, obtained
by the party from the other party; or

b) the specific reimbursement amounts provided for under this Agreement, except
for purposes of administration of benefits.

 

At least 48
hours before either party issues a press release, advertisement, or other media
statement about the business relationship between the parties, that party will
give the other party a copy of the material the party intends to issue.

 

Except as
otherwise required by applicable law or stock exchange rule, Facility will not,
and will not permit any of its representative affiliates, representatives or
advisers to, issue or cause the publication of any press release or make any
other public announcement, including, without limitation, any “tombstone” or
other advertisements, with respect to this Agreement, or the business
relationship between the parties, without the consent of United.

 

9.10        Governing
Law.  This Agreement will be governed by and
construed in accordance with the laws of the State of Minnesota, and any other
applicable law.

 

9.11        Regulatory
Appendices.  One or more regulatory appendix may be
attached to this Agreement, setting forth additional provisions included in
this Agreement in order to satisfy regulatory requirements under applicable
law.  These regulatory appendices, and
any attachments to them, are expressly incorporated into this Agreement and are
binding on the parties to this Agreement. 
In the event of any inconsistent or contrary language between a
regulatory appendix and any other part of this Agreement, including but not
limited to appendices, amendments and exhibits, the regulatory appendix will
control, to the extent it is applicable.

 

9.12        Severability. 
Any provision of this Agreement that is unlawful, invalid or
unenforceable in any situation in any jurisdiction shall not affect the
validity or enforceability of the remaining provisions of this Agreement or the
lawfulness, validity or enforceability of the offending provision in any other
situation or jurisdiction.

 

	
  UnitedHealthcare
  Facility Agreement

  	
  Confidential
  and Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
  0507

  

 

14

 

* Confidential
Treatment Requested by Celera Corporation*

 

9.13        Survival. 
Sections 4.10, 6.7, 6,8, Article VII and sections 8.3 and 9.9 of
this Agreement will survive the termination of this Agreement

 

9.14        Data
Services.  The parties incorporate by reference the Data
Services Appendix attached to this Agreement.

 

THIS
AGREEMENT CONTAINS A BINDING ARBITRATION PROVISION THAT MAY BE ENFORCED BY
THE PARTIES.

 

	
  [Facility]

  	
   

  	
  Address to be used for giving notice to

  Facility under the Agreement:

  
	
   

  	
   

  	
   

  
	
  Signature

  	
  /s/ Frank Ruderman

  	
   

  	
  Street

  	
  839 Mitten Road

  
	
   

  	
   

  	
   

  
	
  Print Name

  	
  Frank Ruderman

  	
   

  	
  City

  	
  Burlingame

  
	
   

  	
   

  	
   

  
	
  Title

  	
  President

  	
   

  	
  State

  	
  CA

  	
   

  	
  Zip Code

  	
  94010

  
	
   

  	
   

  	
   

  	
   

  
	
  Date

  	
  10/30/07

  	
   

  	
  E-mail

  	
  fruderman@bhlinc.com

  

 

United
HealthCare Insurance Company, on behalf of itself, [United Healthcare of
State], and its other affiliates [including without limitation those affiliates
listed in Exhibit 1], as signed by its authorized representative:

 

	
  Signature

  	
  /s/ Edward Novinski

  	
   

  	
  Signature

  	
  /s/ Elena McFann

  
	
   

  	
   

  	
   

  
	
  Print Name

  	
  Edward Novinski

  	
   

  	
  Print Name

  	
  Elena McFann

  
	
   

  	
   

  	
   

  
	
  Title

  	
  SVP, Network Mgmt

  	
   

  	
  Title

  	
  VP, Network Management

  
	
   

  	
   

  	
   

  	
   

  
	
  Date

  	
  10/31/07

  	
   

  	
  Date

  	
  10/30/07

  
	
   

  	
   

  
	
   

  	
  [Address to be used for giving notice to
  United under the Agreement]

  
	
   

  	
   

  
	
   

  	
  Street

  	
  5901 Lincoln Dive MN012-5203

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  City

  	
  Edina

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  State

  	
  MN

  	
   

  	
  Zip Code

  	
  55436

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
  IN THE EVENT THIS AGREEMENT INCLUDES TWO
  SIGNATURE BLOCKS FOR UNITED, THIS AGREEMENT IS NOT BINDING UPON UNITED UNLESS
  EACH OF THE TWO UNITED SIGNATURE BLOCKS ARE EXECUTED.

  
													

 

	
  UnitedHealthcare
  Facility Agreement

  	
  Confidential
  and Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
  0507

  

 

15

 

* Confidential
Treatment Requested by Celera Corporation*

 

	
  x

  	
   

  	
  Appendix 1:
  Facility Location and Service Listings

  
	
  x

  	
   

  	
  Appendix 2:
  Benefit Plan Descriptions

  
	
  x

  	
   

  	
  Appendix 3:
  Additional Protocols

  
	
  x

  	
   

  	
  State
  Regulatory Requirements Appendix (list all states as applicable)

  

 

Alabama,
Alaska, Arizona, Arkansas

California, Colorado, Connecticut

Delaware, District of Columbia

Florida, Georgia, Hawaii

Idaho, Illinois, Indiana, Iowa

Kansas, Kentucky, Louisiana

Maine, Maryland, Massachusetts

Michigan, Mississippi, Missouri, Montana

Nebraska, Nevada, New Hampshire

New Jersey, New Mexico, New York

North Carolina, Ohio, Oklahoma, Oregon

Pennsylvania, Rhode Island, South Carolina

Tennessee, Texas, Utah

Vermont, Virginia, Washington

West Virginia, Wisconsin, Wyoming

 

	
  x

  	
   

  	
  Appendix 4
  Payment Appendices

  
	
  x

  	
   

  	
  Medicare
  Advantage Regulatory Requirements Appendix

  
	
  o

  	
   

  	
  Medicare
  Advantage Payment Appendix

  
	
  o

  	
   

  	
  Medicare
  Select Payment Appendix

  
	
  o

  	
   

  	
  Medicaid
  Regulatory Requirements Appendix

  
	
  o

  	
   

  	
  Medicaid
  Payment Appendix

  
	
  x

  	
   

  	
  Performance
  Standards and Guaranties Appendix

  
	
  x

  	
   

  	
  Data
  Services Appendix

  
	
  o

  	
   

  	
  Exhibit 1
  Affiliates

  
	
  x

  	
   

  	
  Exhibit 2
  Attestation of Ownership

  
	
  o

  	
   

  	
  Other

  

 

	
  UnitedHealthcare
  Facility Agreement

  	
  Confidential
  and Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
  0507

  

 

16

 

* Confidential
Treatment Requested by Celera Corporation*

 

IMPORTANT
NOTE: This Agreement applies to the Covered Services provided at the Facility
locations with Taxpayer Identification Numbers (TIN) and specified markets
listed below. Facility acknowledges its obligation under Sections 3.1 and 4.8
to promptly report any change in Facility’s name or TIN. Failure to do so may
result in denial of claims or incorrect payment. Any additional names, TINs,
service types or locations not listed below will become subject to this
Agreement only upon the prior written agreement of the parties.

 

Appendix
1

Facility Location and Service Listings

 

[Berkeley Heart Lab, Inc.]

 

BILLING ADDRESS

 

[Berkeley
Heart Lab]

[839 Mitten Rd]

[Burlingame, CA 94010]

[330685751]

 

[FACULTY LOCATIONS]

 

	
  [Facility Name]

  	
  [Facility Name]

  	
  [Facility Name]

  
	
  [Street Address]

  	
  [Street Address]

  	
  [Street Address]

  
	
  [City, State Zip]

  	
  [City, State Zip]

  	
  [City, State Zip]

  
	
  [Phone #]

  	
  [Phone #]

  	
  [Phone #]

  
	
  [TIN]

  	
  [TIN]

  	
  [TIN]

  

 

[OTHER SERVICE LOCATIONS]

 

	
  [Facility Name]

  	
   

  
	
  [Street Address]

  	
  [Street Address]

  
	
  [City, State Zip]

  	
  [City, State Zip]

  
	
  [Phone #]

  	
  [Phone #]

  
	
  [TIN]

  	
  [TIN]

  
	
   

  	
   

  
	
  [Facility Name]

  	
   

  
	
  [Street Address]

  	
   

  
	
  [City, State Zip]

  	
   

  
	
  [Phone #]

  	
   

  
	
  [TIN]

  	
   

  
	
   

  	
   

  
	
  [Facility Name]

  	
   

  

 

	
  UnitedHealthcare
  Facility Agreement

  	
  Confidential
  and Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
  0507

  

 

17

 

* Confidential
Treatment Requested by Celera Corporation*

 

Appendix
2

Benefit Plan Descriptions

 

Facility will
participate in the network of physicians and other health care professionals
and providers established by United (“Participating Providers”) for the Benefit
Plan types described below:

 

	
  •

  	
   

  	
  Benefit Plans where
  Customers are offered a network of Participating Providers and must select a
  Primary Physician. Such Benefit Plans may or may not include an
  out-of-network benefit.

  
	
   

  	
   

  	
   

  
	
  •

  	
   

  	
  Benefit Plans where
  Customers are offered a network of Participating Providers but are not
  required to select a primary physician. Such Benefit Plans may or may not
  include an out-of-network benefit.

  
	
   

  	
   

  	
   

  
	
  •

  	
   

  	
  Benefit Plans where
  Customers are not offered a network of Participating Providers from which
  they may receive Covered Services.

  
	
   

  	
   

  	
   

  
	
  •

  	
   

  	
  [Benefit plans or programs
  serviced by OneNet PPO, LLC]

  
	
   

  	
   

  	
   

  
	
  •

  	
   

  	
  [Benefit Plans sponsored,
  issued or administered by any Payer where the Benefit Plan is intended to
  replace, either partially or in its entirety, the traditional Medicare
  coverage (Medicare Part A and Medicare Part B) issued to beneficiaries by the
  Centers for Medicare and Medicaid Services.]

  
	
   

  	
   

  	
   

  
	
  •

  	
   

  	
  [Medicare Advantage
  Private Fee-For-Service plans.]

  

Facility will not
participate in the network of physicians and other health care professionals
and providers established by United for the Benefit Plan types described below:

	
  •

  	
   

  	
  [Benefit plans or programs
  serviced by OneNet PPO, LLC]

  
	
   

  	
   

  	
   

  
	
  •

  	
   

  	
  [Benefit Plans for
  Medicaid Customers (Note: excluding Medicaid from this Agreement does not
  preclude the parties or their affiliates from having a separate agreement
  pertaining to participation in a Medicaid network).]

  
	
   

  	
   

  	
   

  
	
  •

  	
   

  	
  [Benefit Plans for
  Medicaid Customers]

  
	
   

  	
   

  	
   

  
	
  •

  	
   

  	
  [Benefit Plans for
  workers’ compensation benefit programs]

  
	
   

  	
   

  	
   

  
	
  •

  	
   

  	
  [Benefit Plans for
  Medicare Select.]

  

 

 

	
  UnitedHealthcare
  Facility Agreement

  	
  Confidential
  and Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
  0507

  

 

18

 

* Confidential
Treatment Requested by Celera Corporation*

 

Appendix 3

PacifiCare Protocols

 

For Customers
enrolled in Benefit Plans issued or administered by a subsidiary of either
PacifiCare Health Plan Administrators, Inc. or PacifiCare Health Systems,
LLC (“PacifiCare Customers”), Facility will be subject to the Protocols
described in or made available through the PacifiCare Provider Policy and
Procedure Manual (“PacifiCare Manual”). When this Agreement refers to the
Administrative Manual or Guide, it is also referring to the PacifiCare Manual.
The PacifiCare Manual will be made available to Facility on line or upon
request. In the event of any conflict between this Agreement or the
UnitedHealthcare Physician, Health Care Professional, Facility and Ancillary
Provider Administrative Guide or other UnitedHealthcare administrative
protocols, and the PacifiCare Manual, in connection with any matter pertaining
to a PacifiCare Customer, the PacifiCare Manual will govern, unless applicable
statutes and regulations dictate otherwise. United may make changes to the
Administrative Manual or Guide or PacifiCare Manual or other administrative
protocols upon 30 days’ electronic or written notice to Facility.

 

	
  UnitedHealthcare
  Facility Agreement

  	
  Confidential
  and Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
  0507

  

 

19

 

* Confidential
Treatment Requested by Celera Corporation*

 

Representative All-Payer Fee Schedule Sample: [* * *]

 

Unless another
appendix to this agreement applies specifically to a particular Benefit Plan as
it covers a particular customer, the provisions of this appendix apply to
covered services rendered by you to Customers covered by Benefit Plans sponsored,
issued or administered by all participating entities.

 

Unless
specifically indicated otherwise, amounts listed in the fee schedule represent
global fees and may be subject to reductions based on appropriate modifier (for
example, professional and technical modifiers). Any co-payment, deductible or
coinsurance that the Customer is responsible to pay under the Customer’s
Benefit Plan will be subtracted from the listed amount in determining the
amount to be paid by the Payer. The actual payment amount is also subject to
matters described in this Agreement, such as the reimbursement policies. Please
remember that this information is subject to the confidentiality provisions of
this Agreement.

 

[* * *] Reimbursement will be paid according to the schedule listed
below:

 

	
  Type of Service

  	
   

  	
  Primary Fee Source

  	
   

  	
  PCT

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  LAB - PATHOLOGY

  	
   

  	
  Current Year CMS RBRVS (0000000)

  	
   

  	
  [* * *]

  
	
  OFFICE LAB

  	
   

  	
  Current Year CMS Clinical Lab Schedule -
  National Limit

  	
   

  	
  [* * *]

  
	
  CLINICAL LABORATORY

  	
   

  	
  Current Year CMS Clinical Lab Schedule -
  National Limit

  	
   

  	
  [* * *]

  

 

New
Technology:

 

United
acknowledges that Facility may develop and/or provide new technologies and/or
new methodologies during the term of this Agreement. In addition, both parties
acknowledge that there may be other circumstances in which there is no fee in
the fee schedule, or where no relative value units have been established for a
particular service. Facility shall notify United when such new technologies
and/or methodologies are available, or no fee or relative value units have been
established for a particular service and the parties shall develop the fee
and/or relative value units associated with such new technologies and/or
methodologies and/or services.

 

The
methodology for developing new fees or relative value units shall be as
follows:

 

	
  (a)

  	
   

  	
  [* * *]

  
	
   

  	
   

  	
   

  
	
  (b)

  	
   

  	
  [* * *]

  

 

	
  UnitedHealthcare
  Facility Agreement

  	
  Confidential
  and Proprietary

  
	
  UHC/FPA[ANC][State][Nat’l].08.07

  	
  0507

  

 

20

 

* Confidential
Treatment Requested by Celera Corporation*

 

	
  (c)

  	
   

  	
  [* * *]

  
	
   

  	
   

  	
   

  
	
  (d)

  	
   

  	
  [* * *]

  
	
   

  	
   

  	
   

  
	
  (e)

  	
   

  	
  [* * *]

  

 

For reference purposes, the following fee schedules will be used to pay
claims under this agreement:

 

	
  PRODUCTS:

  	
   

  	
  FEE SCHEDULES:

  	
   

  	
  PROVIDER

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  DESCRIPTION

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Commercial

  	
   

  	
  [* * *]

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Medicare

  	
   

  	
  [* * *]

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  

 

	
  UnitedHealthcare
  Facility Agreement

  	
  Confidential
  and Proprietary

  
	
  UHC/FPA[ANC][Nat’l].08.07[State]

  	
  0807

  

 

21

 

* Confidential Treatment
Requested by Celera Corporation*

 

Appendix 4

ATTESTATION
OF BERKELEY HEART LABORATORY

 

State
of California

 

County
of San Mateo

 

Before
me the undersigned Notary appeared Frank Ruderman, who being either known
personally to me and/or presenting proper identification, was duly sworn by me
and testified as follows:

 

(1)           “My name is Frank Ruderman, I am over
the age of 18, fully competent to give this Attestation and have personal
knowledge of the facts stated in it.”

 

(2)           “I hereby certify, that (ENTITY NAME
or NAME OF LAB) has XX% ownership of the (NAME OF THE LAB).”

 

(3)           “I hereby certify that the following
entities have the following percentage ownership of the (NAME OF THE LAB):
(List all entities in joint venture and percentage ownership).”

 

(4)           “I hereby certify that at no time
will any entity control more than the current percentage ownership as set forth
herein of the (NAME THE LAB).”

 

(5)           “I hereby certify that at no time
will the (NAME OF THE LAB) assets, liabilities, revenues and expenses be
consolidated from (NAME OF THE LAB) to any other laboratory or its affiliates.”

 

Further
this Affiant sayeth not.

 

Signed
this          day of
          ,
200    .

 

	
  /s/
  Frank Ruderman

  	
   

  
	
  [Affiant
  signature]

  	
   

  
	
   

  	
   

  
	
  Notary
  Stamp/Certification

  	
   

  
	
   

  	
   

  
	
  October 30,
  2007

  	
   

  
	
  Notary
  Signature

  	
   

  
	
   

  	
   

  
	
  October 30,
  2007

  	
   

  
	
  Date
  of Notary’s Signature

  	
   

  
	
   

  	
   

  
	
  October 15,
  2009

  	
   

  
	
  Expiration
  date of Notary authority

  	
   

  

 

	
  UnitedHealthcare
  Facility Agreement

  	
   

  	
  Confidential and
  Proprietary

  
	
  UHC/FPA[ANC][Nat’l].08.07[State]

  	
   

  	
  0807

  

 

22

 

* Confidential Treatment
Requested by Celera Corporation*

 

1 Performance Standards and
Guarantees Appendix

 

	
  Service Area

  	
   

  	
  Performance Guarantee

  	
   

  	
  Criteria for Measurement

  
	
  Result
  Delivery Response Time

  	
   

  	
  [*
  * *]

  	
   

  	
  [*
  * *]

  
	
  Quality

  	
   

  	
  [* * *]

  	
   

  	
  [* * *]

  
	
  Reporting and Measurement

  	
   

  	
  [* * *]

  	
   

  	
  [* * *]

  
	
  Billing and Reimbursement

  	
   

  	
  [* * *]

  	
   

  	
  [* * *]

  

 

	
  UnitedHealthcare
  Facility Agreement

  	
   

  	
  Confidential and
  Proprietary

  
	
  UHC/FPA[ANC][Nat’l].08.07[State]

  	
   

  	
  0807

  

 

23

 

* Confidential Treatment
Requested by Celera Corporation*

 

Data Services Appendix

 

Pursuant to Section 9.X
of the Agreement, Ancillary Provider agrees to provide Data, as defined herein,
to United and/or its designated data agency (“Data Agency”) as provided herein
consistent with state and federal law including, but not limited to, the Health
Insurance Portability and Accountability Act of 1996 (“HIPAA”). For this
purpose, “Data” means all information obtained or generated by Ancillary
Provider in the course of or in connection with providing Covered Services
pursuant to the Agreement including, without limitation, results for individual
laboratory test analytes and all other data necessary for United and/or Data
Agency (1) to fulfill their obligations to comply with all state and
federal data collection and reporting requirements, including, but not limited
to, the Health Plan Employer Data and Information Set (“HEDIS”); (2) to
perform their Care CoordinationsSM and quality improvement programs,
including physician performance, pharmaceutical safety, Customer health risks
using predictive modeling and the subsequent development of disease management
programs utilized by United; and (3) to research and benchmark data sets.
Data is Customer specific. Nothing in this Appendix shall preclude United from
establishing an electronic connection to Ancillary Provider’s portal that
houses test ordering and results. United represents and warrants that it has
obtained or caused to be obtained any written Customer consents which are
required by applicable law for the release of Customer-identifiable Data as set
forth in this Appendix.

 

Access
to Data

 

The parties acknowledge and
agree that United shall have access to all Data on an “as needed” basis, as
determined by United, subject to any applicable timing requirements set forth
in the Performance Standards Appendix to the Agreement. During the term of the
Agreement, the request for Data by United will generally involve only those
elements or portions of Data consistent with the “Use of Data” and “Data
Schedule” sections of this Appendix (see below). United shall also have access
to all Data for a one-year period following the date Covered Services were last
provided for a Customer.

 

Provision
of Data

 

Ancillary Provider shall
provide Data to United via a media and in a file layout mutually agreed upon by
the parties. The media may be via tapes, spread sheet documents, or electronic
feeds. Data will be provided to United on a daily basis or some other delivery
interval agreed to by the parties. Upon mutual agreement of the parties, this
Data may also be provided to a Data recipient designated by United, other than
Data Agency. The Data reports and/or electronic feeds will contain information
obtained or generated pursuant to the Agreement during the current delivery
interval. The Data reports and feeds shall not contain information for any
previous delivery intervals unless specifically requested by United.

 

Any electronic feeds will be
in a file layout as determined by Data Agency, subject to Ancillary Provider’s
acceptance which will not be unreasonably withheld or delayed, using the HL7
2.4, HL7 2.4 (XML), CALINX Lab 1.1, or other layout as mutually agreed upon by
the parties. The file layout used to send the Data shall include a Logical
Observation Identifiers, Names and Codes (“LOINC”) identifier, an upper and
lower range of normal values, numeric results, test results and Units for the
laboratory test analytes provided. It is also agreed that there will be joint
cooperation between Ancillary Provider and Data Agency in testing the data
fields in connection with any electronic feeds. Such testing will include, but
not be limited to, the provision of test tapes or files by Ancillary Provider
to Data Agency.

 

In the event Data Agency
identifies a problem with a particular Data file that has been sent by
Ancillary Provider, Ancillary Provider shall provide to Data Agency a corrected
Data file, at no cost to United, within 5 business days of the date Ancillary
Provider received notification of such problem from Data Agency or a mutually
agreed upon date.

 

Ancillary Provider will
supply all analyte results, regardless of type. United represents and warrants
that it shall have security measures in place for its receipt of Data from
Ancillary Provider, and acknowledges and

 

	
  UnitedHealthcare
  Facility Agreement

  	
   

  	
  Confidential and
  Proprietary

  
	
  UHC/FPA[ANC][Nat’l].08.07[State]

  	
   

  	
  0807

  

 

24

 

* Confidential Treatment Requested by Celera
Corporation*

 

agrees that United is
responsible for the lawful use by United, Data Agency or other Data recipients
designated by United, of all Data received by them pursuant to this Appendix.

 

Quality
of Data

 

Ancillary Provider hereby
represents and warrants that to the best of its knowledge all Data shall be
accurate and complete, meaning all Data will represent the information received
from the ordering physician and results reported by Ancillary Provider, as appropriate
to the Data request. To the extent required by United, Ancillary Provider
agrees to certify in writing at the time of submission to United, Data Agency,
or other Data recipients designated by United, that all Data is to the best of
its knowledge accurate and complete as defined above. Ancillary Provider
further agrees to hold harmless and indemnify United and Data Agency or other
designees to the extent any fines, penalties, damages, claims, liabilities or
judgments result from Ancillary Provider’s negligence, misconduct or breach of
the warranty set forth in the preceding sentence. United acknowledges, however,
that Ancillary Provider is not responsible for inaccurate or incomplete
information or Data received or obtained from the ordering physician or any
third party, or for any party’s (other than Ancillary Provider’s) improper use
of the Data. Moreover, Ancillary Provider shall not be responsible for
inaccurate or incomplete Customer eligibility information provided to it.
United or its designees shall have the right to audit Ancillary Provider with
regard to the accurateness and completeness of the Data pursuant to Section 4.10
of the Agreement.

 

Use
of Data

 

During and after the term of
the Agreement, United and/or Data Agency may use, transfer, de-identify and
combine Data and the information derived from that Data consistent with state
and federal law including, but not limited to, HIPAA, (1) to fulfill their
obligations to comply with all state and federal data collection and reporting
requirements for, including but not limited to, the HEDIS; (2) to perform
their Care CoordinationSM and quality improvement programs,
including physician performance, pharmaceutical safety, Customer health risks
using predictive modeling and the subsequent development of disease management
programs utilized by United; and (3) to research and benchmark data sets.
Moreover, United and/or Data Agency shall have the right, to the extent
permitted by applicable law, to sell de-identified Data to any third party. 

 

United, Data Agency, and any
other Data recipients designated by United shall comply with all applicable
privacy laws with respect to their use, transfer, de-identification and
combination of Data.

 

Data
Schedule

 

As of the Effective Date of
the Agreement, Ancillary Provider and United agree to the data services and
specifications set forth below. Ancillary Provider shall be responsible for the
preparation and transfer of the Data.

 

	
  ·

  	
   

  	
  Ancillary
  Provider will supply to Data Agency a daily clinical results data feed for
  all Covered Services provided under this Agreement.

  
	
   

  	
   

  	
   

  
	
  ·

  	
   

  	
  Ancillary
  Provider will supply to Data Agency, upon request of United or Data Agency, a
  clinical results data report for Customers or a particular United Affiliate
  or Payer. These report requests may be specific to test analyte(s).

  
	
   

  	
   

  	
   

  
	
  ·

  	
   

  	
  Ancillary
  Provider will supply to Data Agency, upon request of United or Data Agency,
  any ad hoc report pertaining to Data.

  

 

	
  UnitedHealthcare
  Facility Agreement

  	
   

  	
  Confidential and
  Proprietary

  
	
  UHC/FPA[ANC][Nat’l].08.07[State]

  	
   

  	
  0807

  

 

25

 

* Confidential Treatment
Requested by Celera Corporation*

 

United Health Networks

A United Health Group Company

 

BERKELEY HEARTLAB

 

Representative Fee Schedule Sample for : [* *
*] 

Fee amounts as of: 12/01/2007

Report Date: 10/26/2007 *

Site of Service - Linked Schedule ID:

 

	
  CPT

  	
   

  	
  Mod

  	
   

  	
  CPT
  Description

  	
   

  	
  Type of
  Service

  	
   

  	
  Place of

  Service

  	
   

  	
  Fee

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  36415

  	
   

  	
  00

  	
   

  	
  COLLECTION OF VE

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  36416

  	
   

  	
  00

  	
   

  	
  COLLECTION OF CAP

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  80048

  	
   

  	
  00

  	
   

  	
  BASIC METABOLIC

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  80050

  	
   

  	
  00

  	
   

  	
  GENERAL HEALTH P

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  80053

  	
   

  	
  00

  	
   

  	
  COMPREHENSIVE ME

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  80061

  	
   

  	
  00

  	
   

  	
  LIPID PANEL

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  Al

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  80076

  	
   

  	
  00

  	
   

  	
  HEPATIC FUNCTION

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  81000

  	
   

  	
  00

  	
   

  	
  UA DIPSTIK/TABLE

  	
   

  	
  OFFICE LAB

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  81001

  	
   

  	
  00

  	
   

  	
  UA DIP STICK/TAB

  	
   

  	
  OFFICE LAB

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  81002

  	
   

  	
  00

  	
   

  	
  UA DIP STIK/TABL

  	
   

  	
  OFFICE LAB

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  82270

  	
   

  	
  00

  	
   

  	
  BLD OCLT PROXIDA

  	
   

  	
  OFFICE LAB

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  82670

  	
   

  	
  00

  	
   

  	
  ESTRADIOL

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  83036

  	
   

  	
  00

  	
   

  	
  HGB GLYCOSYLATED

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  84153

  	
   

  	
  00

  	
   

  	
  PROSTATE SPECIFI

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  84439

  	
   

  	
  00

  	
   

  	
  THYROXINE; FREE

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  84443

  	
   

  	
  00

  	
   

  	
  THYROID STIMULAT

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  85025

  	
   

  	
  00

  	
   

  	
  BLD COUNT; CMPL

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  85610

  	
   

  	
  00

  	
   

  	
  PROTHROMBIN TIME

  	
   

  	
  OFFICE LAB

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88580

  	
   

  	
  00

  	
   

  	
  SKIN TEST; TUBER

  	
   

  	
  OFFICE LAB

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  87070

  	
   

  	
  00

  	
   

  	
  CULT BACT: NO UR

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  87081

  	
   

  	
  00

  	
   

  	
  CULT PRESUMP PAT

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  87430

  	
   

  	
  00

  	
   

  	
  INF AGT-IMMUNOAS

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  87491

  	
   

  	
  00

  	
   

  	
  INF AGT-DNA/RNA;

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  87880

  	
   

  	
  00

  	
   

  	
  INF AGT-IMMUNOAS

  	
   

  	
  OFFICE LAB

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88142

  	
   

  	
  00

  	
   

  	
  CYTPTH CERV/VAG;

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88173

  	
   

  	
  00

  	
   

  	
  EVAL FINE NEEDL

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88173

  	
   

  	
  26

  	
   

  	
  EVAL FINE NEEDL

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88173

  	
   

  	
  TC

  	
   

  	
  EVAL FINE NEEDL

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88304

  	
   

  	
  00

  	
   

  	
  LEVEL III - SURG

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88304

  	
   

  	
  26

  	
   

  	
  LEVEL III - SURG

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88304

  	
   

  	
  TC

  	
   

  	
  LEVEL III - SURG

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88305

  	
   

  	
  00

  	
   

  	
  LEVEL IV - SURG

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88305

  	
   

  	
  26

  	
   

  	
  LEVEL IV - SURG

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88305

  	
   

  	
  TC

  	
   

  	
  LEVEL IV - SURG

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88307

  	
   

  	
  00

  	
   

  	
  LEVEL V - SURG PA

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88307

  	
   

  	
  26

  	
   

  	
  LEVEL V - SURG PA

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88307

  	
   

  	
  TC

  	
   

  	
  LEVEL V - SURG PA

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88309

  	
   

  	
  00

  	
   

  	
  LEVEL VI - SURG

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88309

  	
   

  	
  26

  	
   

  	
  LEVEL VI - SURG

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88309

  	
   

  	
  TC

  	
   

  	
  LEVEL VI - SURG

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88312

  	
   

  	
  00

  	
   

  	
  SPECIAL STAINS;

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88312

  	
   

  	
  26

  	
   

  	
  SPECIAL STAINS;

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88312

  	
   

  	
  TC

  	
   

  	
  SPECIAL STAINS;

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88331

  	
   

  	
  00

  	
   

  	
  PATH CONS-SURG; 1

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88331

  	
   

  	
  26

  	
   

  	
  PATH CONS-SURG; 1

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88331

  	
   

  	
  TC

  	
   

  	
  PATH CONS-SURG; 1

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88342

  	
   

  	
  00

  	
   

  	
  IMMUNOHISTOCHEMI

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88342

  	
   

  	
  26

  	
   

  	
  IMMUNOHISTOCHEMI

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  88342

  	
   

  	
  TC

  	
   

  	
  IMMUNOHISTOCHEMI

  	
   

  	
  LAB – PATHOLOGY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  Q0091

  	
   

  	
  00

  	
   

  	
  SCR PAP SMER; OB

  	
   

  	
  CLINICAL LABORATORY

  	
   

  	
  All

  	
   

  	
  $

  	
  [***]

  	
   

  

 

Last Routine Maintenance
Update: 10-01-2007

Default Percent of Charges: [***]

Anesthesia Conversion Factor:
[***]

Anesthesia Rounding Option: [***]

 

Unless specifically indicated
otherwise, amounts listed in the fee schedule represent global fees and may be
subject to reductions based on appropriate modifier (for example, professional
and technical modifiers).  Any co-payment,
deductible or coinsurance that the customer is responsible to pay under the
customer’s benefit contract will be subtracted from the listed amount in
determining the amount to be paid by the payer. 
The actual payment amount is also subject to matters described in this
agreement, such as the payment policies. 
Please remember that this information is subject to the confidentiality
provisions of this agreement

 

* Note:  Maintenance to this fee schedule occurs
routinely and may still occur after the report date for the fee amounts
selected.

 

Confidential and
Proprietary          Not for Distribution
to Third Parties

 

1

 

* Confidential Treatment
Requested by Celera Corporation*

 

United
Health Networks

A United
Health Group Company

 

Additional Information About Your Fee
Schedule

 

[* * *]

 

The purpose of
this document is to provide additional information about this fee schedule,
including clarity about the fee sources used to derive fees and the type of
routine maintenance changes that you can expect.

 

Primary Fee Source

 

The primary
fee source is the main fee source used as the basis for deriving the fee within
each category of codes. For instance, if the fee schedule for a given category
of codes is derived by applying a particular conversion factor to the relative
value units (RVUs) in the CMS fee schedule, those CMS relative value units are
the primary fee source.

 

Alternate (Gap-Fill) Fee Source

 

Alternate (or “gap
fill”) fee sources are used to fill gaps in the primary fee sources. For
example, if a new CPT code has been created within the category of codes
discussed above, and CMS has not yet established an RVU value for that code, we
use one of the sources that exist within the industry to fill that gap, such as
but not limited to Ingenix Essential RBRVS and CMS Part B Carriers. For
that CPT code, we adopt the RVU value established by the gap fill-fee source,
and determine the fee schedule amount for that CPT code by applying to the
gap-fill RVU the same conversion factor that we apply to the CMS RVU for those
CPT codes that have CMS RVUs. At such time in the future as CMS publishes its
own RVU value for that CPT code, we would begin using the primary fee source,
CMS, to derive the fee for that code and no longer use the alternate source.

 

Percent of Charge Default

 

In the event
that a fee is not sourced by either the primary or alternate fee source, such
as services submitted using unclassified or miscellaneous codes, the codes are
subject to correct coding review and may be priced at the default Percent of
Charge indicated in the attached document(s).

 

Fee Source Links

 

·                  CMS Relative Values and Fee
Schedules: www.cms.hhs.gov

·                  MICROMEDEX Red Book:
www.micromedex.com

·                  Ingenix Essential RBRVS:
www.ingenixonline.com

·                  American Society of
Anesthesiologists: www.asahq.org

 

Site of Service

 

This fee
schedule applies no variation in pricing based on where the service is
performed.

 

Routine Maintenance

 

United
routinely updates its fee schedule in an effort to stay abreast of current
coding practices widely used in the health care industry; in response to price
changes for immunizations and injectable medications; and to remain in
compliance with the intent of the contractual agreement. Routine maintenance
occurs when United mechanically incorporates revised information created by a
third party that is the source for a portion of the fee schedule. United will
not generally attempt to communicate routine maintenance of this nature and
will generally implement updates to be effective within 90 days from the date
of final publication from one of our primary or alternate fee sources. Providers
may expect the following types of fee updates to their fee schedules:

 

a. Changes to Relative Value Units,
Conversion Factors, or Flat Rate Fees

 

This fee schedule follows a “Current
Year” construction methodology. It is generally intended to remain current with
RVU, Conversion Factor, and Flat Rate Fee (non-RVU based fees such as Durable
Medical Equipment fees) changes as the basis for deriving fees. As such,
changes published by the primary and/or alternate fee sources will similarly be
reflected in this fee schedule.

 

Last Routine Maintenance
Update: 10-01-2007

Default Percent of Charges: [***]

Anesthesia Conversion Factor: [***]

Anesthesia Rounding Option: [***]

 

Unless specifically indicated otherwise, amounts listed
in the fee schedule represent global fees and may be subject to reductions
based on appropriate modifier (for example, professional and technical
modifiers).  Any co-payment, deductible
or coinsurance that the customer is responsible to pay under the customer’s
benefit contract will be subtracted from the listed amount in determining the
amount to be paid by the payer.  The
actual payment amount is also subject to matters described in this agreement,
such as the payment policies.  Please
remember that this information is subject to the confidentiality provisions of
this agreement.

 

* Note: 
Maintenance to this fee schedule occurs routinely and may still occur
after the report date for the fee amounts selected.

 

	
  Confidential and Proprietary

  	
  Not for Distribution to Third Parties

  

 

2

 

* Confidential Treatment
Requested by Celera Corporation*

 

Additional Information About Your Fee
Schedule

 

[* * *]

 

b. Price Changes for Immunizations and
Injectable Medications

 

United routinely updates its
fee schedule in response to price changes for immunizations and injectable
medications published by the primary and/or alternate fee sources. United
currently utilizes CMS Drug Pricing and Thomson Micromedex Red Book AWP as its
primary fee sources. Fees are generally updated on a calendar quarter basis
within 90 days from the date of final publication but with an effective date of
the first day of the quarter following publication. In the event that an
Average Wholesale Price (AWP) or an Average Sales Price (ASP) has not yet been
published by Red Book or CMS for a particular injectable drug, UnitedHealthcare
may develop and implement gap-fill fees using available fee information,
including NDC-based pricing, or other available national fee sources. Once Red
Book and CMS do publish a fee for the drug, the AWP or ASP fee will replace the
gap-fill fee at the time of the next quarterly fee schedule update.

 

c. CPT/HCPCS

 

United routinely updates its
fee schedule in response to additions, deletions, and changes to CPT codes by
the American Medical Association; HCPCS codes by the Centers for Medicaid and
Medicare Services; and in response to similar changes (additions and revisions)
to other service coding and reporting conventions that are widely used in the
health care industry. Ordinarily, United’s fee schedule is updated using the
original construction methodology along with the then-current RVU of the
published CPT code.

 

United is
committed to providing transparency related to our fee schedules. If you have
questions about this fee schedule, please contact Network Management at the
address and phone number on your network participation agreement or you may use
our fee schedule look-up function on the web at www.unitedhealthcareonline.com
or contact our Voice Enabled Telephonic Self Service line at (877) 842-3210.

 

Last Routine Maintenance
Update: 10-01-2007

Default Percent of Charges: [***]

Anesthesia Conversion Factor: [***]

Anesthesia Rounding Option: [***]

 

Unless specifically indicated otherwise, amounts listed
in the fee schedule represent global fees and may be subject to reductions
based on appropriate modifier (for example, professional and technical
modifiers).  Any co-payment, deductible
or coinsurance that the customer is responsible to pay under the customer’s
benefit contract will be subtracted from the listed amount in determining the
amount to be paid by the payer.  The
actual payment amount is also subject to matters described in this agreement,
such as the payment policies.  Please
remember that this information is subject to the confidentiality provisions of
this agreement.

 

* Note: 
Maintenance to this fee schedule occurs routinely and may still occur
after the report date for the fee amounts selected.

 

	
  Confidential and Proprietary

  	
  Not for Distribution to Third Parties

  

 

3

 

* Confidential Treatment
Requested by Celera Corporation*

 

Ancillary Provider Participation Agreement

Medicare Advantage Regulatory Appendix

 

The provisions
contained in this Appendix supplement the Ancillary Provider Participation
Agreement between Ancillary Provider and United (the “Agreement’). Because
Ancillary Provider has agreed to provide Covered Services to Medicare Customers
who receive their coverage under Medicare Advantage contracts between the
Centers for Medicare and Medicaid Services (“CMS”) and United or other Payers
(collectively “Medicare Advantage Plans’), applicable Medicare Advantage
regulations and CMS guidelines require that the provisions contained in this Appendix
be part of the Agreement. For Medicare Advantage Plans, this Appendix
supersedes any inconsistent provisions that may be found elsewhere in the
Agreement.

 

·                  Data. Ancillary
Provider shall cooperate with United in its efforts to report to CMS all statistics
and other information related to its business, as may be requested by CMS.  Ancillary Provider shall send to United all
encounter data and other Medicare program-related information as may be
requested by United, within the timeframes specified and in a form that meets
Medicare program requirements. By submitting encounter data to United,
Ancillary Provider represents to United, and upon United’s request Ancillary
Provider shall certify in writing, that the data is accurate and complete,
based on Ancillary Provider’s best knowledge, information and belief. If any of
this data turns out to be inaccurate or incomplete, according to Medicare
Advantage rules, United may withhold or deny payment to Ancillary Provider.

 

·                  Policies.
Ancillary Provider shall cooperate and comply with all of United’s policies and
procedures, credentialing plan and provider administrative manual.

 

·                  Payment. United
shall promptly process and pay Ancillary Provider’s claim no later than 60 days
after United receives all appropriate information as described in United’s
administrative procedures. If Ancillary Provider is responsible for making
payment to subcontracted providers, Ancillary Provider shall pay them within
this same timeframe.

 

·               Customer Protection.
Ancillary Provider agrees that in no event, including but not limited to,
non-payment by United or an intermediary, insolvency of United or an
intermediary, or breach by United of the Agreement, shall Ancillary Provider
bill, charge, collect a deposit from, seek compensation, remuneration or
reimbursement from, or have any recourse against any Customer or person (other
than United or an intermediary) acting on behalf of the Customer for Covered
Services provided pursuant to the Agreement. 
This provision does not prohibit Ancillary Provider from collecting
copayments, coinsurance, or fees for services not covered under the Customer’s
Benefit Plan and delivered on a fee-for-service basis to the Customer. This
provision does not prohibit Ancillary Provider and a Customer from agreeing to
continue services solely at the expense of the Customer, as long as Ancillary
Provider has clearly informed the Customer that the Benefit Plan may not cover
or continue to cover a specific service or services.

 

In the event of United’s or an intermediary’s
insolvency or other cessation of operations or termination of United’s contract
with CMS, Ancillary Provider shall continue to provide Covered Services to a
Customer through the later of the period for which premium has been paid to
United on behalf of the Customer, or, in the case of Customers who are
hospitalized as of such period or date, until the Customer’s discharge. Covered
Services for a Customer confined in an inpatient facility on the date of
insolvency or other cessation of operations shall continue until the Customer’s
continued confinement in an inpatient facility is no longer medically
necessary.

 

This provision shall be
construed in favor of the Customer, shall survive the termination of the
Agreement regardless of the reason for termination, including United’s
insolvency, and shall supersede any oral or

 

 

* Confidential Treatment
Requested by Celera Corporation*

 

written contrary agreement
between Ancillary Provider and a Customer or the representative of a Customer
if the contrary agreement is inconsistent with this provision.

 

For the purpose of this
provision, an “intermediary” is a person or entity authorized to negotiate and
execute the Agreement on behalf of Ancillary Provider or on behalf of a network
through which Ancillary Provider elects to participate.

 

·                  Eligibility.
Ancillary Provider agrees to immediately notify United in the event Ancillary
Provider is or becomes disbarred, excluded, suspended, or otherwise determined
to be ineligible to participate in federal health care programs. Ancillary
Provider shall not employ or contract with, with or without compensation, any
individual or entity that has been disbarred, excluded, suspended or otherwise
determined to be ineligible to participate in federal health care programs.

 

·                  Laws. The
parties shall comply with all applicable Medicare laws, regulations and CMS
instructions and shall cooperate with the other’s efforts to comply. Ancillary
Provider shall also cooperate with United in its efforts to comply with its
contract with CMS.

 

·                  Records. The
Secretary of Health and Human Services, the Comptroller General and United
shall have the right to audit, evaluate and inspect any books, contracts,
medical records, patient care documentation and other records belonging to
Ancillary Provider that pertain to the Agreement and other program-related
matters deemed necessary by the person conducting the audit, evaluation, or
inspection. This right shall extend through 10 years from the later of the last
day of a CMS contract period or completion of any audit, or longer in certain
instances described in the applicable Medicare Advantage regulations. Ancillary
Provider shall make its premises, facilities and equipment available for these
activities. Ancillary Provider shall maintain medical records in an accurate
and timely manner. Ancillary Provider shall ensure that Customers have timely
access to medical records and information that pertain to them. The parties
shall safeguard the privacy of any health information that identifies a
Customer and abide by all federal and state laws regarding privacy,
confidentiality and disclosure of medical records and other health and Customer
information.

 

·                  Accountability.
Ancillary Provider agrees that United oversees and is accountable to CMS for
any responsibilities that are contained in its contract with CMS, including
those that United may delegate to Ancillary Provider or others. Any
responsibilities that are delegated must be specified in a written arrangement
with the other party. The arrangement must include any reporting requirements,
a right of revocation, performance monitoring by United, ongoing review,
approval and auditing of credentialing processes, if applicable, and compliance
with all applicable Medicare laws, regulations and CMS instructions.

 

·                  Subcontracts.
If Ancillary Provider has subcontract arrangements with other providers to
deliver Covered Services to United’s Customers, Ancillary Provider shall ensure
that its contracts with those subcontracted providers contain all of the
provisions in this Appendix and shall provide proof of such to United upon
request.Exhibit 10.21

 

FORM OF

 

CELERA CORPORATION 2008 STOCK INCENTIVE PLAN

 

FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT

 

NON-QUALIFIED
STOCK OPTION AGREEMENT dated as of [Grant Date] by and between Celera
Corporation, a Delaware corporation (the “Company”), and [Name], an [employee/director]
of the Company or one of its subsidiaries (“you”).

 

1. Grant of Option. The Company hereby grants to
you an option (the “Option”) to purchase [Total Number of Shares] shares of its
Celera Corporation Common Stock, par value $.01 per share (the “Celera Stock”),
under the terms of the Celera Corporation 2008 Stock Incentive Plan (the “Plan”).

 

2. Purchase Price of Option. The purchase price of the
shares of Celera Stock subject to the Option is $[Purchase Price] per share.

 

3. Expiration Date of Option. The Option will expire as of
12:00 a.m. midnight (New York time) on [10 Year Anniversary of Grant Date]
(the “Expiration Date”), unless it is terminated earlier as provided in this
Agreement.

 

4. Exercise. The Option may be exercised in accordance
with the vesting schedule attached hereto as Exhibit A. Except as provided
below, the Option may not be exercised unless you are on the date of exercise,
and have been at all times from the date of grant to the date of exercise, an
employee of the Company or one of its subsidiaries.

 

5. Termination of Employment. If your employment with the
Company or a subsidiary is terminated by you or the Company or a subsidiary for
any reason other than Cause (as defined below), retirement under any retirement
plan provided by the Company or a subsidiary, disability, or death, you may
exercise the Option, to the extent that you would otherwise be entitled to do
so at the date of termination of employment, at any time within 90 days after
the date of termination, but not after the Expiration Date.

 

6. Termination of Service for Cause.
If your employment with the Company or a subsidiary is terminated by
the Company or a subsidiary for Cause, the Option will be immediately forfeited
in full upon termination (regardless of the extent to which the Option may have
been exercisable as of that time). For purposes of this paragraph 6 only, “Cause”
is defined as (a) any act which is in bad faith and to the detriment of
the Company or one of its subsidiaries or (b) a material breach of any
agreement with or material obligation to the Company or one of its
subsidiaries.

 

7. Retirement. If you retire under the
terms of any retirement plan provided by the Company or one of its
subsidiaries, you may exercise the Option, to the extent that you would
otherwise be entitled to do so at the date of retirement, at any time within
one year after the date of retirement, but not after the Expiration Date.

 

8. Disability. If you become totally and
permanently disabled, you may exercise the Option in full (without regard to
the exercise schedule set forth in paragraph 4) at any time within one year
after the date of termination of employment as a result of disability, but not
after the Expiration Date.

 

1

 

9. Death. If you die while employed by the Company or
one of its subsidiaries, the Option may be exercised (to the extent that you
would have been entitled to do so at the date of your death) by your executor
or administrator (or other person at the time entitled by law to your rights
under the Option) at any time within one year after the date of your death, but
not after the Expiration Date.

 

10. Exercise of Option. The Option may be exercised
by giving written notice in the form specified by the Company to the Corporate
Secretary at the principal office of the Company specifying the number of
shares of Celera Stock to be purchased, or in such other manner as the Company
may specify to you from time to time. However, the Option may not be exercised
with respect to a fractional share. The purchase price of the shares as to
which the Option is exercised must be paid in full at the time of exercise, at
your election, (a) in U.S. currency, (b) by tendering to the Company
shares of Celera Stock owned by you (if necessary for such period of time
required by the Company to avoid a charge to earnings for financial accounting
purposes) having a Fair Market Value (as defined in the Plan) equal to the
aggregate purchase price of the shares as to which the Option is being
exercised, (c) a combination of U.S. currency and/or previously owned
shares of Celera Stock valued at Fair Market Value, (d) if permitted by
the Compensation Committee of the Board of Directors (the “Committee”) pursuant
to a “same day sale” program, (e) if permitted by the Committee, by means
of a net exercise, or (f) by payment of such other consideration as the
Committee from time to time determines. For purposes of this paragraph, Fair
Market Value will be determined as of the business day immediately preceding
the day on which the Option is exercised.

 

11. Conditions to Exercise.  The exercise of
the Option following termination of employment, to the extent and for the time
periods provided above, is subject to the satisfaction of the conditions that
you have not (a) rendered services or engaged directly or indirectly in
any business which in the opinion of the Committee competes with or is in
conflict with the interests of the Company, or (b) violated any written
agreement with the Company, including, without limitation, any confidentiality
agreement. Your violation of either clause (a) or (b) of the
preceding sentence will result in the immediate forfeiture of any Options held
by you.

 

12. Tax Withholding Obligations. As a condition to the
delivery of shares of Celera Stock upon the exercise of the Option, you agree
to pay to the Company an amount sufficient to satisfy any applicable tax,
social insurance, or social security withholding obligations arising in
connection with the Option or your participation in the Plan. Alternatively,
subject to any limitations imposed by law, you agree that the Company and your
employer are expressly authorized to deduct the appropriate withholding taxes
from your salary or any other cash payments due to you in order to satisfy any
income, social, or other employment-related taxes related to your Option or
your participation in the Plan.

 

13. Rights as a Stockholder. You will not have any rights
as a stockholder with respect to the shares of Celera Stock subject to the
Option prior to the issuance to you of a certificate for such shares.

 

14. Non-Transferability. The Option may not be
transferred other than by will or by the laws of descent and distribution, and
the Option may be exercised, during your lifetime, only by you or your guardian
or legal representative.

 

2

 

15. Change of Control. Subject to the terms of the
Plan, the Option will become immediately exercisable in full (without regard to
the exercise schedule set forth in paragraph 4) upon the occurrence of any of
the events set forth in Section 11 of the Plan.

 

16. No Right to Continued Employment. Neither the
Option nor this Agreement confers upon you any right to continue to be an
employee of the Company or any of its subsidiaries or interferes in any way
with the right of the Company or any of its subsidiaries to terminate your
employment at any time. Except as provided in this Agreement, the Option will
terminate upon the termination of your employment for any reason. The Option
will not be reinstated if you are subsequently reinstated as an employee of the
Company or any subsidiary.

 

17. No Right to Future Benefits. The Plan and the benefits
offered under the Plan are provided by the Company on an entirely discretionary
basis, and the Plan creates no vested rights in participants. Neither the
Option nor this Agreement confers upon you any benefit other than as
specifically set forth in this Agreement and the Plan. You understand and agree
that the benefits offered under the Option and the Plan are not part of your
salary and that receipt of the Option does not entitle you to any future
benefits under the Plan or any other plan or program of the Company. The award
of the Option is not part of normal or expected compensation for purposes of
calculating any: severance, resignation, redundancy, end of service, or bonus
payments; long-service awards; pension or retirement benefits; or similar
payments.

 

18. Compliance with Law. No shares of Celera Stock
will be issued upon the exercise of the Option unless counsel for the Company
is satisfied that such issuance will be in compliance with all applicable laws.

 

19. Entire Agreement. This Agreement and the Plan contain
the entire agreement between you and the Company regarding the Option and
supersede all prior or contemporaneous arrangements or understandings with
respect to the Option.

 

20. Terms of Plan Govern. This Agreement and the
terms of the Option will be governed by the terms of the Plan which is hereby
incorporated by reference in this Agreement. In the event of any ambiguity in
this Agreement or any inconsistency between the terms of this Agreement and the
terms of the Plan, the terms of the Plan will govern. By your signature below,
you acknowledge receipt of the Plan Summary and agree to be bound by all of the
terms of the Plan.

 

21. Amendments. The Option or the Plan may,
subject to certain exceptions, be amended by the Committee at any time in any
manner. However, no amendment of the Option or the Plan will adversely affect
in any material manner any of your rights under the Option without your
consent.

 

22. Governing Law. This Agreement will be
governed by and construed in accordance with the internal laws of the State of
Delaware.

 

23. Data Privacy. By signing this Agreement,
you consent to the collection, use, processing, and transfer of personal data
as described in this paragraph. You understand that the Company and its
subsidiaries hold some personal information about you, including your name,
home address and telephone number, date of birth, social security number,
social insurance number or other employee identification number, salary,
nationality, job title, any shares of stock or directorships held in the
Company, details of all options or any other entitlement to shares of stock
awarded, canceled, purchased, vested, unvested or outstanding in your favor,
for the purpose of managing and administering the Plan (“Data”). You further
understand that the Company and/or its subsidiaries will transfer Data among
themselves as necessary for the purpose of implementation, administration, and
management of your participation in the Plan, and that the Company and/or

 

3

 

any of its subsidiaries may
each further transfer Data to any third parties assisting the Company in the
implementation, administration, and management of the Plan. You understand that
these recipients may be located in the United States and elsewhere. You
authorize them to receive, possess, use, retain, and transfer the Data, in
electronic or other form, for the purposes of implementing, administering, and
managing your participation in the Plan, including any transfer of such Data as
may be required for the administration of the Plan and/or the subsequent
holding of shares of stock on your behalf to a broker or other third party with
whom you may elect to deposit any shares of stock acquired pursuant to the
Plan. You understand and further authorize the Company and/or any of its
subsidiaries to keep Data in your personnel file. You also understand that you
may, at any time, review Data, require any necessary amendments to Data, or
withdraw the consents herein by contacting the Company in writing. You further
understand that withdrawing your consent may affect your ability to participate
in the Plan.

 

IN WITNESS
WHEREOF, this Agreement has been duly executed by the
undersigned as of the day and year first written above.

 

 

	
   

  	
   

  	
  CELERA
  CORPORATION

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  
	
   

  	
   

  	
   

  

 

	
  Accepted and Agreed:

  
	
   

  
	
   

  
	
  [Name]

  

 

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}]]